NS
Nikhil Sureshchandra Uchat
About Nikhil Sureshchandra Uchat
Data last updated:
Nikhil Sureshchandra Uchat is a Director at Parmax Pharma Limited (since 2023). The company operates in Pharma. Parmax Pharma Limited reported revenue of ₹28.24 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parmax Pharma Limited L24231GJ1994PLC023504 | Director | 25 Apr 2023 | 1994 | ₹28.24 Cr (FY 2025) | Active |
Board colleagues of Nikhil Sureshchandra Uchat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ami Shah Rajeshbhai | 08158605 | Parmax Pharma Limited | Director |
| Bhakti Rameshbhai Aghera | Parmax Pharma Limited | Company Secretary | |
| Keyur Dineshbhai Vora | Parmax Pharma Limited | Cfo | |
| Pradeep Ramniklal Gosalia | 01130646 | Parmax Pharma Limited | Director |
| Salma Badrudin Thobhani | 11616267 | Parmax Pharma Limited | Director |
| Umang Alkesh Gosalia | 05153830 | Parmax Pharma Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Sureshchandra Uchat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Sureshchandra Uchat
Nikhil Sureshchandra Uchat currently holds 1 directorship: Parmax Pharma Limited (Director, since 25 Apr 2023, revenue ₹28.24 Cr (FY 2025)).
Nikhil Sureshchandra Uchat was first appointed on 25 Apr 2023 as Director at Parmax Pharma Limited.
The current boards of Nikhil Sureshchandra Uchat's companies include Ami Shah Rajeshbhai (Parmax Pharma Limited), Bhakti Rameshbhai Aghera (Parmax Pharma Limited), Keyur Dineshbhai Vora (Parmax Pharma Limited), Pradeep Ramniklal Gosalia (Parmax Pharma Limited), Salma Badrudin Thobhani (Parmax Pharma Limited), Umang Alkesh Gosalia (Parmax Pharma Limited).